STAT3 and neoplasm: One such mechanism involves tumor-derived exosomal surface HSP72 that, through the HSP72-TLR axis, initiates the signaling for the T cell-dependent immunosuppressive function of MDSCs, ultimately leading to STAT3 activation (53).